Neurogene Inc. (NGNE)
NASDAQ: NGNE · Real-Time Price · USD
16.16
-0.41 (-2.47%)
At close: Jun 27, 2025, 4:00 PM
16.35
+0.19 (1.18%)
After-hours: Jun 27, 2025, 5:45 PM EDT
Neurogene Employees
Neurogene had 107 employees as of December 31, 2024. The number of employees increased by 16 or 17.58% compared to the previous year.
Employees
107
Change (1Y)
16
Growth (1Y)
17.58%
Revenue / Employee
$8,645
Profits / Employee
-$755,794
Market Cap
230.47M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 107 | 16 | 17.58% |
| Dec 31, 2023 | 91 | 9 | 10.98% |
| Dec 31, 2022 | 82 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
NGNE News
- 22 days ago - Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 6 weeks ago - Neurogene Announces Evidence-Based Monitoring and Treatment Intended to Reverse Rare Hyperinflammatory Syndrome Associated with High-Dose AAV - Business Wire
- 7 weeks ago - Neurogene Reports First Quarter 2025 Financial Results and Highlights Recent Updates - Business Wire
- 2 months ago - Neurogene Announces Upcoming Oral Presentation on Monitoring and Treatment to Reverse Rare Complication of High Dose Gene Therapy at the ASGCT Annual Meeting - Business Wire
- 3 months ago - Neurogene Announces Peer-Reviewed Publication Demonstrating Gene Therapy Candidate NGN-401 with EXACT™ Technology Regulates Transgene Expression in Preclinical Models of Rett Syndrome - Business Wire
- 3 months ago - Neurogene Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Updates - Business Wire
- 4 months ago - Neurogene to Participate in Upcoming Conferences - Business Wire
- 7 months ago - Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Neurogene Inc. (NGNE) And Encourages Shareholders to Reach Out - Accesswire